University of North Carolina
176
18
29
126
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
5.1%
9 terminated/withdrawn out of 176 trials
93.3%
+6.8% vs industry average
12%
21 trials in Phase 3/4
35%
44 of 126 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (176)
CD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin Lymphoma
Role: collaborator
Prevention of Postpartum Hemorrhage With Tranexamic Acid
Role: collaborator
Impact of OptiCreatine on Plasma Creatine and Gastrointestinal Effects in Males and Females
Role: collaborator
Transformative Research in Diabetic Nephropathy
Role: collaborator
Low Birthweight and Preterm Infant Feeding Trial and Supportive Care Package: Implementation Research
Role: collaborator
Clinical Registry of Long-Term Dental Outcomes in Head and Neck Cancer Patients
Role: collaborator
ISTH/ANRS 0409s INTEGRATE Lassa Fever Study
Role: collaborator
Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease
Role: collaborator
LIFT-UP: Randomized Controlled Trial of Fortification of Human Milk
Role: collaborator
Effectiveness Study of a Lifestyle Intervention Versus Metformin in Mothers With Recent Gestational Diabetes
Role: collaborator
Leveraging Community Health Workers and a Digital Health System to Improve the Timeliness of Child Well Visits
Role: collaborator
Parent Involvement in Adolescent Obesity Treatment
Role: collaborator
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
Role: collaborator
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
Role: collaborator
ACHIEVE Brain Health Follow-Up Study
Role: collaborator
Individualizing Treatment for Asthma in Primary Care (Full Study)
Role: collaborator
Prenatal Genetic Diagnosis by Genomic Sequencing
Role: collaborator
iSIPsmarter: An RCT Evaluating the Efficacy of a Technology-Based Intervention to Reduce Sugary Drinks in Rural Appalachia
Role: collaborator
Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL
Role: collaborator
ACHIEVE Hearing Intervention Follow-Up Study
Role: collaborator